Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biopharmaceutical Companies 2024
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.
  1. AstraZeneca

    World Rank (Jan-05-2024)
    48
    Market Cap (Jan-05-2024)
    213.330 Billion USD
    World Rank (Jul-30-2023)
    44
    Market Cap (Jul-30-2023)
    221.350 Billion USD
    World Rank (Dec-25-2022)
    40
    Market Cap (Dec-25-2022)
    210.670 Billion USD
    World Rank (Jan-07-2022)
    71
    Market Cap (Jan-07-2022)
    178.12 Billion USD
    Annual Revenue in USD
    44,351 Million USD
    Annual Operating Income in USD
    4,561 Million USD
    Annual Net Income in USD
    3,288 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, Astrazeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford and are launching Phase III trials. Headquarters is in UK.

    AstraZeneca Product Sales split by Disease Area for year ending Dec-2021

    Facts About Company

    AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,288 million USD for year ending Dec-2022.

    AstraZeneca has 83,500 employees as on 2022 when compared to with 76,100 employees as on 2020 and 70,600 employees as on 2019.

    AstraZeneca has total assets of 96,483 million USD as on Dec-2022 when compared to 66,729 million USD as on Dec-2020.

    AstraZeneca Product Sales split of 44,351 Million USD by Disease Area for year ending Dec-2022

  2. Amgen

    World Rank (Jan-05-2024)
    73
    Market Cap (Jan-05-2024)
    162.250 Billion USD
    World Rank (Jul-30-2023)
    105
    Market Cap (Jul-30-2023)
    126.300 Billion USD
    World Rank (Dec-25-2022)
    80
    Market Cap (Dec-25-2022)
    140.820 Billion USD
    World Rank (Jan-07-2022)
    113
    Market Cap (Jan-07-2022)
    128.03 Billion USD
    Annual Revenue in USD
    26,323 Million USD
    Annual Operating Income in USD
    9,566 Million USD
    Annual Net Income in USD
    6,552 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

    Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

    Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

    Facts About Company

    As on 2022, Amgen has 25,200 employees.

    Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

    Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

    Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

    Split of Annual Revenue by business segment for period ending Dec-2021:

  3. Vertex Pharmaceuticals

    World Rank (Jan-05-2024)
    129
    Market Cap (Jan-05-2024)
    107.235 Billion USD
    World Rank (Jul-30-2023)
    161
    Market Cap (Jul-30-2023)
    91.186 Billion USD
    World Rank (Dec-25-2022)
    182
    Market Cap (Dec-25-2022)
    74.361 Billion USD
    World Rank (Jan-07-2022)
    323
    Market Cap (Jan-07-2022)
    56.41 Billion USD
    Annual Revenue in USD
    8,930 Million USD
    Annual Operating Income in USD
    4,365 Million USD
    Annual Net Income in USD
    3,322 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    VERTEX PHARMACEUTICALS is USA Based Bio-Technology, Bio-Pharmaceutical and Healthcare Company.It have research and development sites, manufacturing facilities and offices around the world. The company locations are North America, Europe, Australia, South America.

    As on 2022, VERTEX PHARMACEUTICALS has 4,500 employees.

    VERTEX PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 8,930 million USD.

  4. Bristol-Myers Squibb Company

    World Rank (Jan-05-2024)
    130
    Market Cap (Jan-05-2024)
    106.418 Billion USD
    World Rank (Jul-30-2023)
    100
    Market Cap (Jul-30-2023)
    129.010 Billion USD
    World Rank (Dec-25-2022)
    66
    Market Cap (Dec-25-2022)
    154.980 Billion USD
    World Rank (Jan-07-2022)
    96
    Market Cap (Jan-07-2022)
    139.46 Billion USD
    Annual Revenue in USD
    46,159 Million USD
    Annual Operating Income in USD
    9,104 Million USD
    Annual Net Income in USD
    6,327 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

    BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

    Company has over 32,200 employees as on 2021. Headquarters is in USA.

    BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

    BMS be the biopharma company that transforms patients' lives through science.

    Facts About Company

    As on 2022, Bristol-Myers Squibb has 34,300 employees.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2022 was 46,159 million USD.

    Bristol-Myers Squibb annual net income generated for period ending Dec-2022 was 6,327 million USD.

    As on 2021, BMS had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2021 was 46,385 million USD.

  5. Gilead Sciences

    World Rank (Jan-05-2024)
    133
    Market Cap (Jan-05-2024)
    105.265 Billion USD
    World Rank (Jul-30-2023)
    154
    Market Cap (Jul-30-2023)
    95.871 Billion USD
    World Rank (Dec-25-2022)
    120
    Market Cap (Dec-25-2022)
    106.300 Billion USD
    World Rank (Jan-07-2022)
    180
    Market Cap (Jan-07-2022)
    89.39 Billion USD
    Annual Revenue in USD
    27,281 Million USD
    Annual Operating Income in USD
    10,974 Million USD
    Annual Net Income in USD
    4,592 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    GILEAD SCIENCES INC is world’s largest bio-pharmaceutical companies. As on Dec-2021, Gilead Sciences had 14,400 employees across six continents and headquarters is in USA,

    As on 2022, GILEAD SCIENCES INC has 17,000 employees.

    GILEAD SCIENCES INC annual revenue generated for period ending Dec-2022 was 27,281 million USD.

    GILEAD SCIENCES INC annual net loss generated for period ending Dec-2022 was 4,592 million USD.

  6. Regeneron Pharmaceuticals

    World Rank (Jan-05-2024)
    144
    Market Cap (Jan-05-2024)
    100.011 Billion USD
    World Rank (Jul-30-2023)
    174
    Market Cap (Jul-30-2023)
    81.855 Billion USD
    World Rank (Dec-25-2022)
    166
    Market Cap (Dec-25-2022)
    79.143 Billion USD
    World Rank (Jan-07-2022)
    279
    Market Cap (Jan-07-2022)
    64.93 Billion USD
    Annual Revenue in USD
    12,172 Million USD
    Annual Operating Income in USD
    4,994 Million USD
    Annual Net Income in USD
    4,338 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    REGENERON PHARMACEUTICALS is Bio-Pharmaceutical company with headquarters is in New York, USA.

    As on 2022, REGENERON PHARMACEUTICALS has 11,851 employees.

    Facts About Company

    REGENERON PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 12,172 million USD.

    REGENERON PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 4,338 million USD.

    As on 2022, they had 11,851 employees. They had 7 FDA approved medicines.

  7. Samsung Biologics

    World Rank (Jan-05-2024)
    433
    Market Cap (Jan-05-2024)
    41.719 Billion USD
    World Rank (Jul-30-2023)
    418
    Market Cap (Jul-30-2023)
    43.803 Billion USD
    World Rank (Dec-25-2022)
    354
    Market Cap (Dec-25-2022)
    44.809 Billion USD
    World Rank (Jan-07-2022)
    417
    Market Cap (Jan-07-2022)
    46.57 Billion USD
    Annual Revenue in USD
    2,356 Million USD
    Annual Operating Income in USD
    772 Million USD
    Annual Net Income in USD
    626 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    CEO
    Company Profile

    Samsung Biologics is Biopharmaceutical Manufacturing Company with headquarters is in South Korea. It provides development, manufacturing , laboratory testing services at every stage for Biopharmaceutical products while meeting the evolving needs of the global healthcare industry. The company has 2,587 employees as on 2022.

  8. Moderna

    World Rank (Jan-05-2024)
    436
    Market Cap (Jan-05-2024)
    41.430 Billion USD
    World Rank (Jul-30-2023)
    397
    Market Cap (Jul-30-2023)
    45.234 Billion USD
    World Rank (Dec-25-2022)
    174
    Market Cap (Dec-25-2022)
    76.483 Billion USD
    World Rank (Jan-07-2022)
    188
    Market Cap (Jan-07-2022)
    86.71 Billion USD
    Annual Revenue in USD
    18,870 Million USD
    Annual Operating Income in USD
    9,420 Million USD
    Annual Net Income in USD
    8,360 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Moderna is Biotechnology sector company with headquarters is in Massachusetts, USA. It has done good work on Covid-19 vaccine.

    As on 2022, Moderna has 3,900 employees.

    Moderna annual revenue generated for period ending Dec-2022 was 18.87 billion USD.

    Moderna annual net income generated for period ending Dec-2022 was 8.36 billion USD.

    Moderna annual revenue generated for period ending Dec-2021 was 16,471 million USD.

  9. Celltrion

    World Rank (Jan-05-2024)
    509
    Market Cap (Jan-05-2024)
    35.824 Billion USD
    World Rank (Jul-30-2023)
    1,134
    Market Cap (Jul-30-2023)
    16.020 Billion USD
    World Rank (Dec-25-2022)
    883
    Market Cap (Dec-25-2022)
    18.618 Billion USD
    World Rank (Jan-07-2022)
    985
    Market Cap (Jan-07-2022)
    21.21 Billion USD
    Annual Revenue in USD
    1,793 Million USD
    Annual Operating Income in USD
    508 Million USD
    Annual Net Income in USD
    422 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Celltrion is a Biopharmaceutical company. The headquarters is in South Korea.

    Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.

  10. Lonza Group

    World Rank (Jan-05-2024)
    598
    Market Cap (Jan-05-2024)
    30.535 Billion USD
    World Rank (Jul-30-2023)
    414
    Market Cap (Jul-30-2023)
    44.006 Billion USD
    World Rank (Dec-25-2022)
    460
    Market Cap (Dec-25-2022)
    36.081 Billion USD
    World Rank (Jan-07-2022)
    316
    Market Cap (Jan-07-2022)
    57.62 Billion USD
    Annual Revenue in USD
    7,148 Million USD
    Annual Operating Income in USD
    1,559 Million USD
    Annual Net Income in USD
    1,396 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical, Bio Technology and Chemical Company with headquarters is in Basel, Switzerland.

Share

Ads